When is treatment indicated for Enterococcus faecalis isolated from a urine specimen, and what are the recommended antimicrobial regimens?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Treatment of E. faecalis in Urine

Treatment of Enterococcus faecalis isolated from urine is indicated only when the patient has symptomatic urinary tract infection; asymptomatic bacteriuria should NOT be treated except in pregnant women or patients undergoing urologic procedures with anticipated mucosal bleeding. 1

When to Treat vs. When NOT to Treat

DO NOT TREAT (Asymptomatic Bacteriuria):

  • Asymptomatic bacteriuria with E. faecalis should not be treated in the vast majority of patients 1
  • This includes:
    • Diabetic patients
    • Elderly patients (community or long-term care)
    • Patients with spinal cord injury
    • Patients with indwelling catheters (unless catheter removal is planned)
    • Non-pregnant premenopausal or postmenopausal women
    • Patients with neutropenia

The 2019 IDSA guideline strongly emphasizes that screening for and treating asymptomatic bacteriuria drives antimicrobial resistance without patient benefit 1. Even obtaining urine cultures when not clinically indicated promotes inappropriate antimicrobial use.

DO TREAT (Symptomatic UTI):

  • Acute cystitis: dysuria, frequency, urgency, suprapubic pain
  • Acute pyelonephritis: fever, flank pain, costovertebral angle tenderness
  • Catheter-associated UTI (CA-UTI): fever, rigors, altered mental status, hemodynamic instability, flank pain, costovertebral angle tenderness, acute hematuria, pelvic discomfort, or dysuria in a catheterized patient
  • Pregnant women (even if asymptomatic) 1
  • Patients undergoing urologic procedures with anticipated mucosal bleeding 1

Antimicrobial Selection for E. faecalis

First-Line Agents:

E. faecalis typically shows excellent susceptibility to beta-lactams, making them the preferred choice 2, 3:

  • Ampicillin (oral or IV): First-line agent
  • Amoxicillin (oral): Equivalent alternative
  • Amoxicillin-clavulanate (oral): Acceptable, though clavulanate adds no benefit for E. faecalis 4
  • Penicillin: Also effective 3
  • Piperacillin: Alternative option 3

Alternative Oral Agents for Uncomplicated Cystitis:

  • Nitrofurantoin: Effective for lower UTI only (not for pyelonephritis) 5, 3
  • Fosfomycin: Single-dose option for uncomplicated cystitis 5
  • Fluoroquinolones (ciprofloxacin, levofloxacin): Only if susceptible; resistance rates vary but can exceed 50% 2

Parenteral Agents for Severe/Complicated Infections:

  • Ampicillin IV: Preferred
  • Ampicillin + gentamicin: For severe infections (pyelonephritis, bacteremia, endocarditis) - the aminoglycoside provides synergy 6
  • Imipenem: Remains effective against E. faecalis 2
  • Vancomycin: Reserve for beta-lactam allergy or resistance (rare in E. faecalis) 5, 6
  • Linezolid: For vancomycin-resistant strains (uncommon in E. faecalis) 5, 6
  • Daptomycin: Alternative for resistant strains 5

Critical Resistance Considerations

E. faecalis shows markedly different resistance patterns than E. faecium 2, 6:

  • E. faecalis: Low resistance to ampicillin (typically <5%), vancomycin resistance rare (1-2%) 2, 6
  • E. faecium: High resistance to ampicillin (>99%), vancomycin resistance common (48-55%) 2, 6

Always obtain culture and susceptibility testing before treating symptomatic enterococcal UTI 7. The wide spectrum of potential resistance, particularly high-level aminoglycoside resistance (40-70% of E. faecalis strains), necessitates susceptibility-guided therapy 8.

Duration of Treatment

Uncomplicated Cystitis:

  • 3 days for women ≤65 years after catheter removal 7
  • 5-7 days for standard uncomplicated cystitis

Complicated UTI/Pyelonephritis:

  • 7 days if prompt symptom resolution 7
  • 10-14 days if delayed response 7

Catheter-Associated UTI:

  • Replace catheter if in place ≥2 weeks before initiating treatment 7
  • Obtain culture from freshly placed catheter when feasible 7
  • 7 days with prompt resolution; 10-14 days with delayed response 7

Common Pitfalls to Avoid

  1. Do not treat asymptomatic bacteriuria - this is the most common error and drives resistance 1
  2. Do not assume E. faecalis and E. faecium have similar susceptibilities - they are vastly different 2, 6
  3. Do not use aminoglycosides as monotherapy - high-level resistance is common; use only for synergy with beta-lactams in severe infections 8
  4. Do not use nitrofurantoin for pyelonephritis - inadequate tissue penetration 5
  5. Do not obtain screening urine cultures in asymptomatic patients - this promotes inappropriate treatment 1

References

5
Research

Treatment of resistant enterococcal urinary tract infections.

Current infectious disease reports, 2010

6
Research

[Enterococcal infections and their treatment options].

Klinicka mikrobiologie a infekcni lekarstvi, 2021

Related Questions

How should an isolated Enterococcus faecalis in a urine culture be interpreted and managed?
How should Enterococcus isolated from urine be interpreted and managed?
What antibiotic is recommended for treating an adult urinary tract infection caused by Enterococcus faecalis?
What empiric antimicrobial therapy should be started for an adult patient with aerobic cultures showing moderate growth Enterococcus faecalis and heavy growth of Gram‑negative bacilli?
Should an asymptomatic patient with an Enterococcus faecalis urine culture be treated with antibiotics?
What is the appropriate concentration and maximum dose of bupivacaine for subcutaneous infiltration in an adult patient without amide‑type anesthetic allergy?
How should I evaluate and manage a 21-year-old anxious male who believes he has reduced sweating and becomes nervous in hot environments?
Is it safe to use isotonic saline nasal spray in a 21‑month‑old child?
What is the appropriate management for a patient who ingested 0.05 mg of bromadiolone (rat poison)?
What antibiotic is recommended for treating an adult urinary tract infection caused by Enterococcus faecalis?
How should periorbital edema be treated on an outpatient basis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.